A systematic review of gastritis as an immune-related adverse event in clinical interventions
Immune checkpoint inhibitors (ICIs) are crucial in cancer treatment, and the associated immune-related adverse events (irAEs) have garnered significant attention, yet reports on associated immune related gastritis are limited. The diagnosis of immune related gastritis remains predominantly exclusion...
Saved in:
Main Authors: | Fei Su (Author), Wen-Xuan Fan (Author), Yan Zhang (Author), Xiao-Ling Zhang (Author), Yun-Yi Du (Author), Wei-Ling Li (Author), Wen-Qing Hu (Author), Jun Zhao (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer
by: Wen-Xuan Fan, et al.
Published: (2024) -
Biomarkers and risk factors for the early prediction of immune-related adverse events: a review
by: Ying Zhang, et al.
Published: (2022) -
Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy
by: Yunyi Du, et al.
Published: (2024) -
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
by: Wei-Ling Li, et al.
Published: (2022) -
Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)